Kezar Life Sciences, Inc. (KZR) Reports Q2 Loss of $0.30/sh
Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q2 EPS of ($0.30), versus ($0.34) reported last year.
For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.